WO1996025962A1 - Lentille intra-oculaire souple - Google Patents
Lentille intra-oculaire souple Download PDFInfo
- Publication number
- WO1996025962A1 WO1996025962A1 PCT/JP1996/000361 JP9600361W WO9625962A1 WO 1996025962 A1 WO1996025962 A1 WO 1996025962A1 JP 9600361 W JP9600361 W JP 9600361W WO 9625962 A1 WO9625962 A1 WO 9625962A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- monomer
- acrylate
- intraocular lens
- general formula
- lens
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/12—Esters of monohydric alcohols or phenols
- C08F220/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
- C08F220/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
- C08F220/1808—C8-(meth)acrylate, e.g. isooctyl (meth)acrylate or 2-ethylhexyl (meth)acrylate
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/22—Esters containing halogen
- C08F220/24—Esters containing halogen containing perhaloalkyl radicals
Definitions
- the present invention relates to a soft intraocular lens that can be easily inserted from a small censored wound. Specifically, the lens can be folded into small pieces, inserted into the HM while holding the lens, and then released even if force is released.
- -im I This is a flexible I inner crotch lens that is stable without being sticky, for example, it is turned into a geometric shape with a suitable ll "J, such as at 260 seconds.
- small incision surgery aimed at reducing postoperative L vision has become popular.
- small incision surgery lenses include coatings and milk
- JP-A-4 one No. 292,609 discloses a flexible intraocular lens comprising a co-IS union containing two or more arylalkyl (meth) acrylates and a crosslinkable monomer as monomer components.
- the flexible intraocular lens described in this patent publication has a high refractive index, the lens thickness is reduced. There is also the advantage of being able to do so. When the lens is bent, it has a drawback that it sticks in the folded state, is difficult to separate, and the insertion procedure into the eye is not easy.
- Example 1 of U.S. Pat. No. 5,331,073 phenoxyethyl acrylate, n-hexyl acrylate, and ethylene glycol dimethacrylate, a crosslinkable monomer, were used as monomer components.
- phenoxyethyl acrylate, n-hexyl acrylate, and ethylene glycol dimethacrylate a crosslinkable monomer.
- An object of the present invention is to bend the lens to a small angle, hold the lens, insert the lens into the eye while holding it, and then release the held force without sticking the optical parts of the lens together.
- An object of the present invention is to provide a soft intraocular lens which recovers its original shape and stabilizes in an appropriate time of about 0 to 60 seconds.
- a flexible intraocular lens made of a copolymer obtained by copolymerizing a specific monomer mixture containing a monomer and a monomer has the flexibility to be bent, and even if the optical parts of the lens are folded and come into contact with each other. Without sticking, it was found that when the held force was released, the original shape was recovered and stabilized in an appropriate time of about 20 to 60 seconds, for example.
- the present invention has been completed based on the above findings, and has the general formula
- R 2 is hydrogen or a methyl group
- R 3 is hydrogen or a methyl group, and is a linear or branched alkyl group of C to
- the gist of the present invention is a soft intraocular lens comprising a co-JS union containing as an essential monomer component.
- FIG. 1 is a transmittance curve of the intraocular lens made of the copolymer obtained in Example 1 in the ultraviolet. The best form for impressing
- the first monomer component constituting the soft intraocular lens of the present invention is represented by the above general formula (I) Is a perfluorooctylethyloxypropylene (meth) acrylate, which reduces the surface tackiness of a soft intraocular lens material, for example, in about 20 to 60 seconds at an appropriate time. It is an important component for adding the function of recovering and stabilizing the shape.
- R 1 is hydrogen or a methyl group, but is preferably a methyl group.
- the monomer of the general formula (I) is preferably 5 to 20% by weight, more preferably? It can be added in the range of ⁇ 15% by weight. If the amount of the monomer (I) is less than 5% by weight, sufficient effects are exhibited to reduce the surface tackiness and to recover and stabilize the original shape in a suitable time of, for example, about 20 to 60 seconds. If the f (%) exceeds 20 times f (%), the shape recovery of the obtained soft intraocular lens is deteriorated and the shape becomes poor.
- the two monomer components composing the soft intraocular lens of the present invention are 2-phenylethyl (meth) acrylate represented by the above general formula (II), which gives a high refractive index to the soft intraocular lens material. It is an essential component.
- R 2 is hydrogen or a methyl group, but is preferably a methyl group.
- the monomer of the general formula ( ⁇ ) can be added preferably in the range of 40 to 60% by weight, more preferably 42 to 56% by weight. If the content is less than 40% by weight, it is difficult to remove the foldable cows from the lens material. Lens materials are not preferred because they lose flexibility and are difficult to bend.
- the second monomer component constituting the soft intraocular lens of the present invention is an alkyl (meth) acrylate represented by the above general formula (II), and is an essential component for imparting flexibility to the soft intraocular lens material. It is.
- R 3 is hydrogen or a methyl group, but is preferably hydrogen, and R or C.1 to C, 2 is a linear or branched alkyl group.
- Specific examples of the monomer represented by the general formula ( ⁇ ⁇ ) include n-butyl acrylate, isobutyl acrylate, isoamyl acrylate, hexyl acrylate, —Ethylhexyl acrylate, octyl acrylate, isooctyl acrylate, decyl acrylate, isodecyl acrylate, and the like.
- the general (III) monomer can be added in a range of preferably 30 to 50% by weight, more preferably 35 to 46 ⁇ % PJ. If it is less than 30% by weight, it is difficult to obtain sufficient flexibility of the lens material, and if it exceeds 50% by weight, the surface tackiness of the lens material tends to increase, which is not preferable.
- the fourth monomer component constituting the soft intraocular lens of the present invention is a crosslinkable monomer, and may be used alone or in combination of two or more.
- the crosslinkable monomer is
- H1 ethylene glycol dimethacrylate
- EDMA ethylene glycol dimethacrylate
- ethylene glycol dimethacrylate ethylene glycol dimethacrylate
- triethylene glycol dimethacrylate ethylene glycol dimethacrylate
- Plate tetraethylene glycol dimethacrylate, 1,4-butanediol dimethacrylate, 1,4-butanediol diacrylate, 1,6-hexanediol dimethacrylate and the like.
- the use of the crosslinkable monomer is preferably 0.5 to 4% by weight based on the total amount of the monomers represented by the general formulas (I), (II) and (III). Particularly preferably, it is 1 to 3.5% by weight. If it is less than 0.5% S%, the effect of introducing a crosslinkable monomer is unlikely to be exhibited, and if it exceeds 4 ff (% by mass), the number of crosslinking points increases and the material becomes brittle, and the mechanical strength tends to decrease.
- a monomer having an ultraviolet absorbing ability can be used as a component of the soft intraocular lens, and as an example, an ultraviolet absorbing ability represented by the following general formula (IV) can be used. Can be mentioned.
- X is a hydrogen atom or a chlorine atom
- R 5 is a hydrogen or a methyl group.
- Specific examples of the monomer having the ultraviolet absorbing ability represented by the general formula (IV) include: — [2-Hydroxy-1 5— (? —Methyl cryloyloxetylcarbamoyloxetil)] phenyl— 2 H-benzotriazole (hereinafter referred to as CHMP), 2— [2-hydroxy 1-Methyl chloroyloxetil calvamoyloxetil)] phenyl-1H-benzotriazole.
- the amount of the monomer having an ultraviolet absorbing ability is preferably 0.05 to 3% by weight based on the total amount of the monomers of the general formulas (I), (II) and (III). Particularly preferably, it is in the range of 1 to 2% by weight. If the amount is less than 0.05% by weight, the effect of preventing ultraviolet rays cannot be expected, and even if ⁇ exceeds 3 ffi fl ;:%, remarkable improvement in the effect of preventing ultraviolet rays cannot be expected.
- a dye in order to color the soft inner lens material, it is possible to use, for example, a dye!
- a polymerization initiator is added to the above-mentioned monomer mixture, and the mixture is sufficiently stirred to prepare a homogeneous monomer mixture.
- the polymerization is carried out by the following method.
- the usual method is a method in which, after adding a radical E polymerization initiator, the temperature is raised stepwise or continuously in a temperature range of 40 to 120 ° C, or irradiation with ultraviolet light, visible light, or the like is performed. .
- I'J radical.01 initiators examples include azobisvaleronitrile and azobisisobutyronitrile (AIBN), which are known as general radical polymerization initiators.
- Organic initiators such as azo initiators and bis (4-tert-butylcyclohexyl) peroxide dicarbonate can be used.
- the amount of the initiator used is preferably about 0.05 to 0.5% by weight based on the total amount of the monomers.
- the copolymer constituting the flexible intraocular lens of the present invention may be prepared by filling the above monomer mixture into a mold having a desired intraocular lens shape into a mold to obtain a molded product. After a rod-shaped, block-shaped, or plate-shaped copolymer is obtained in a mold or container, the i.body can be formed into an intraocular lens shape by cutting and grinding at a low temperature.
- the supporting part of the lens is made separately from the lens
- the support portion of the lens may be manufactured separately from the lens and attached to the lens later, or may be integrally formed with the lens.
- the support material include polypropylene and PMMA.
- Adhesiveness When the optical part is released by holding it at 36 ° C room temperature after grasping and bending the optical part with an intraocular lens insertion device, the optical parts do not adhere to each other at all. Shape recovery: 20-60 seconds
- BRM perfluorooctylethyloxypropylene methacrylate
- PEMA 2-phenylethylethyl acrylate
- This solution was injected into a mold that sandwiched a Teflon frame (thickness lmm) with glass plates (thickness 1.3 mm) from above and below, and into a polypropylene mold for making intraocular lenses made of polypropylene. .
- the mold and the mold were transferred into a pressure I furnace, and polymerized at 110 ° C for 2 hours in a nitrogen atmosphere with a pressure of 2 kgf / cm 2 to form a film and an optical part of the intraocular lens.
- the obtained copolymer is immersed in 100 ml of methanol to remove unpolymerized monomers. After removal, a sample that was sufficiently dried was used as a test sample, and various physical properties were measured. The measurement of the material was performed according to the following method.
- test sample in water was observed with the naked eye, and the transparency and discoloration were examined.
- the IE unit of the Wi lens optical part shape was gripped by the inner lens insertion device, and when the force was released in a room at 36 ° C, the pressure of the lens optical part was increased by ⁇ '.
- a film-like copolymer (length 10 mm, width 5 mm, thickness about lmm) was bent using a universal testing machine manufactured by Instron Japan Co., Ltd., and the bending load of the film-like copolymer was measured.
- the bending speed was 10 Omm / min
- the bending distance was 6 mm
- the force at that time was used as an index of the force required for bending the copolymer ( ⁇ is represented by g).
- the refractive index at e-line (546.1 nm) at 36 ° C was measured using a refractometer manufactured by Kago Corporation.
- Table 1 shows the physical property results. From Table 1, it can be seen that the copolymer obtained in this example has no tackiness, a small bending load (easy to bend), and a shape in about 30 seconds. Was to do.
- CHMP which has an ultraviolet absorbing ability, made the intraocular lens made of the co-Si union obtained in this example excellent in the effect of preventing ultraviolet rays. 1 g of this 1-day-break strip is soaked in 50 ml of steamed water, and
- FIG. 1 shows an ultraviolet absorption curve of the intraocular lens made of the copolymer obtained in this example.
- Example 2 In the same manner as in Example 1, a monomer composed of BRM, PEMA, BA, CHMP, and EDMA was added to the solution, and AIBN was added to the mixture to perform ff (copolymerization. A copolymer was obtained. The ill at the beginning of the radical iTi ⁇ lj was reduced to 1. Thereafter, the non-IB monomer was removed by the same operation as in Example 1, and the physical properties were measured, and the results are shown in Table 1.
- the intraocular lens made of the sympathetic union obtained in the example had no tackiness, had a small bending load (easy to bend), and was shaped and rotated in about 25 to 40 seconds. By introducing the compound, the intraocular lens made of the copolymer obtained in this example was excellent in the effect of preventing ultraviolet rays.
- the intraocular lens made of the copolymer obtained in this example has no tackiness and a small bending load (bending and bending). It took about 30 seconds to reshape the shape. Further, by adding CHMP, the intraocular lens made of the copolymer obtained in this example was excellent in the effect of preventing ultraviolet rays.
- Example 5 In the same manner as in Example 5, AIBN was added to a monomer mixture composed of BRM, PEMA, EHA, CHMP and EDMA, and polymerization was carried out to obtain a copolymer.
- Table 1 shows the amounts of the polymerization monomer, the crosslinking monomer, and the radical polymerization initiator. Thereafter, unreacted monomers were removed by the same operation as in Example 5, and each rare property was measured. The results are shown in Table 1.
- the intraocular lens made of the Jt coalescence obtained in the present example had no stickiness, had a small bending load (easy to bend), and was shaped in about 30 to 50 seconds.
- CHMP the intraocular lens made of the copolymer obtained in this example was excellent in the effect of preventing ultraviolet rays.
- the copolymer was prepared in the same manner as in Example 1 except that 2,2,2-trifluoroethyl methacrylate (hereinafter referred to as TFEMA) was used instead of the BRM used in Example 1 (CHMP was Did not guide). From 0.58 g (8 wt%) of TFEMA, 3 g (50 wt%) of PEMA, 52 g (42 wt%) of BA, 18 g of EDMAO (3 wt% based on the total amount of TFEMA, PE MA and BA) AIBN 0 ⁇ 0 1 2 g (PEMA, PEMA and (0.2% by weight based on the total amount of BA), and polymerization was carried out to obtain a copolymer.
- TFEMA 2,2,2-trifluoroethyl methacrylate
- Example 1 Thereafter, unpolymerized monomers were removed by the same operation as in Example 1, and various physical properties were measured. The results are shown in Table 1. Compared with the polymer obtained in Example 1, the polymer obtained in this comparative example had a larger bending load (harder to bend), and the shape recovery was extremely slow.
- a copolymer was obtained in the same manner as in Example 1 except that methyl methacrylate (hereinafter, referred to as MMA) was used in place of the BRM used in Projection Example 1 (CHMP was not introduced).
- MMA 0.48 g (81 ⁇ %), ⁇ 3 g (50% by weight), BA 2.52 g (42% by weight), EDMAO.
- 18 g (3% by weight based on the total amount of MMA, PE MA and BA) 0.012 g (0.2% by weight based on the total amount of MMA, PEMA and BA) of AIBN was added to the resulting monomer mixture to carry out polymerization to obtain a copolymer.
- unpolymerized monomers were removed by the same operation as in Example 1, and various physical properties were measured.
- Table 1 The polymer obtained in the present comparative example has a larger folding load (it is harder to bend) and the shape recovery is extremely slow as compared with the 21-mer obtained in Example 1. Was something.
- a copolymer was obtained in the same manner as in Example 5 except that TFEMA was used instead of BRM used in Example 5 (CHMP was not introduced). 6 g (10% by weight) of TFEM AO., 3 g (50% by weight) of PEMA, 2.4 g (40% by weight) of EHA, .18 g of EDMAO (3IE based on the total amount of TFEMA, PE MA and E HA; :%), 0.012 g of AIBN (0.2% by weight based on the total view of TFEM A, PEM A and EHA) was added to the monomer mixture, and polymerization was carried out to obtain a co-combination. .
- Example 5 Same as Example 5 except that MMA was replaced by fl Copolymer was obtained in the same manner (CHMP was not introduced). ⁇ 0.6 g (10 wt%), PEMA3 g (50 wt%), EHA2.4 g (40 wt%), EDMAO. 18 g (3 wt% based on the total amount of MMA, PEMA and EHA) 012 g (0.2% by weight based on the total amount of MMA, PEMA and EHA) of AIBN was added to the monomer mixture to carry out polymerization to obtain a copolymer. Thereafter, unpolymerized monomers were removed by the same operation as in Example 5, and various physical properties were measured. The result is shown in FIG. Compared with the polymerized polymer obtained in Example 5, the polymer obtained in the tree comparative example has a folded I mountain: the fill is harder (harder to bend), and the shape circuit is extremely small. It was a terrible thing.
- PEA 2-phenylphenylacrylate
- BDDA 3 Oml one butanediol ⁇ chestnut rate
- the soft intraocular lenses of Examples 1 to 7 have no surface tackiness, a small bending load (easy to bend), and about 20 to 60 when the held force is released. In about ⁇ seconds, it recovered to its original shape and stabilized. This is especially true with the introduction of perfluorooctyl oxypropylene (meth) acrylate, which reduces the meta-viscosity of the lens material and furthermore does not cause the oriyama I-load 71 to ignite. This is because the effect of recovering the shape at an appropriate speed was exhibited.
- the flexible intraocular lens according to the present invention is capable of holding the lens in a small bent state and inserting it into the eye, and then releasing the force without causing the lens optics to adhere to each other. Inexpensive according to the shape of the question. Therefore, it has the effect that it can be assimilated in the eye without giving the image of the intracapsular cells.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Prostheses (AREA)
- Eyeglasses (AREA)
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9606822A BR9606822A (pt) | 1995-02-23 | 1996-02-19 | Lente intraocular macia |
MX9704748A MX9704748A (es) | 1995-02-23 | 1996-02-19 | Lente intraocular blando. |
DE69618764T DE69618764T2 (de) | 1995-02-23 | 1996-02-19 | Weiche intraokuläre linse |
EP96902474A EP0811393B1 (en) | 1995-02-23 | 1996-02-19 | Soft intraocular lens |
NZ301359A NZ301359A (en) | 1995-02-23 | 1996-02-19 | A soft intraocular lens |
AU46767/96A AU703753B2 (en) | 1995-02-23 | 1996-02-19 | Soft intraocular lens |
KR1019970704409A KR100334483B1 (ko) | 1995-02-23 | 1996-02-19 | 연성안내렌즈 |
CA002207010A CA2207010C (en) | 1995-02-23 | 1996-02-19 | Soft intraocular lens |
HK98105067A HK1005796A1 (en) | 1995-02-23 | 1998-06-09 | Soft intraocular lens |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7/35228 | 1995-02-23 | ||
JP7035228A JP2967093B2 (ja) | 1995-02-23 | 1995-02-23 | 軟性眼内レンズ |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996025962A1 true WO1996025962A1 (fr) | 1996-08-29 |
Family
ID=12435988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/000361 WO1996025962A1 (fr) | 1995-02-23 | 1996-02-19 | Lentille intra-oculaire souple |
Country Status (15)
Country | Link |
---|---|
US (1) | US5814680A (ja) |
EP (1) | EP0811393B1 (ja) |
JP (1) | JP2967093B2 (ja) |
KR (1) | KR100334483B1 (ja) |
CN (1) | CN1093769C (ja) |
AU (1) | AU703753B2 (ja) |
BR (1) | BR9606822A (ja) |
CA (1) | CA2207010C (ja) |
DE (1) | DE69618764T2 (ja) |
ES (1) | ES2171647T3 (ja) |
HK (1) | HK1005796A1 (ja) |
IN (1) | IN187504B (ja) |
MX (1) | MX9704748A (ja) |
NZ (1) | NZ301359A (ja) |
WO (1) | WO1996025962A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6187042B1 (en) | 1998-04-15 | 2001-02-13 | Alcon Laboratories, Inc. | Intraocular lens coating compositions |
US6210438B1 (en) * | 1998-04-15 | 2001-04-03 | Alcon Laboratories, Inc. | Bicomposite intraocular lens and method for its preparation |
EP0968727A4 (en) * | 1997-12-02 | 2004-03-31 | Hoya Healthcare Corp | INTRAOCULAR LENSES AND METHOD FOR PRODUCING INFUSED INTRAOCULAR LENSES |
WO2007020713A1 (ja) | 2005-08-18 | 2007-02-22 | Koken Co., Ltd. | 生体内に埋設可能な細胞培養担体 |
US9949822B2 (en) | 1998-05-29 | 2018-04-24 | Johnson & Johnson Surgical Vision, Inc. | Intraocular lens for inhibiting cell growth and reducing glare |
US11484402B2 (en) | 2011-11-08 | 2022-11-01 | Alcon Inc. | Accommodating intraocular lenses |
US11751991B2 (en) | 2002-12-12 | 2023-09-12 | Alcon Inc. | Accommodating intraocular lenses and methods of use |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW473653B (en) * | 1997-05-27 | 2002-01-21 | Clariant Japan Kk | Composition for anti-reflective film or photo absorption film and compound used therein |
US6277940B1 (en) * | 1997-08-20 | 2001-08-21 | Menicon Co. Ltd | Material for a soft intraocular lens |
JP4053631B2 (ja) * | 1997-10-08 | 2008-02-27 | Azエレクトロニックマテリアルズ株式会社 | 反射防止膜又は光吸収膜用組成物及びこれに用いる重合体 |
USRE38935E1 (en) | 1998-10-29 | 2006-01-10 | Advanced Medical Optics, Inc. | Intraocular lenses made from polymeric compositions and monomers useful in said compositions |
US6245106B1 (en) * | 1998-10-29 | 2001-06-12 | Allergan Sales, Inc. | Intraocular lenses made from polymeric compositions and monomers useful in said compositions |
US6241766B1 (en) | 1998-10-29 | 2001-06-05 | Allergan Sales, Inc. | Intraocular lenses made from polymeric compositions |
CA2348495C (en) * | 1998-10-29 | 2008-07-15 | Allergan Sales, Inc. | Intraocular lenses made from polymeric compositions |
US6554424B1 (en) | 1999-03-01 | 2003-04-29 | Boston Innovative Optices, Inc. | System and method for increasing the depth of focus of the human eye |
JP4149068B2 (ja) * | 1999-03-02 | 2008-09-10 | 株式会社メニコン | 眼用レンズ材料 |
WO2000057213A1 (en) * | 1999-03-23 | 2000-09-28 | Medennium, Inc. | Polymeric material compositions and intraocular lenses made from same |
AUPQ197799A0 (en) | 1999-08-02 | 1999-08-26 | Commonwealth Scientific And Industrial Research Organisation | Hydrophilic biomedical compositions |
US6271281B1 (en) * | 1999-08-26 | 2001-08-07 | Medennium, Inc. | Homopolymers containing stable elasticity inducing crosslinkers and ocular implants made therefrom |
US8048155B2 (en) | 2002-02-02 | 2011-11-01 | Powervision, Inc. | Intraocular implant devices |
US10045844B2 (en) | 2002-02-02 | 2018-08-14 | Powervision, Inc. | Post-implant accommodating lens modification |
DE10218570B4 (de) * | 2002-04-26 | 2007-10-18 | Lohmann Gmbh & Co Kg | Acrylatcopolymere und daraus erhältliche Haftklebemassen zum Verkleben von niederenergetischen Oberflächen sowie ihre Verwendung |
US6737448B2 (en) * | 2002-06-03 | 2004-05-18 | Staar Surgical Company | High refractive index, optically clear and soft hydrophobic acrylamide copolymers |
US8361145B2 (en) | 2002-12-12 | 2013-01-29 | Powervision, Inc. | Accommodating intraocular lens system having circumferential haptic support and method |
US8328869B2 (en) | 2002-12-12 | 2012-12-11 | Powervision, Inc. | Accommodating intraocular lenses and methods of use |
CA2517576A1 (en) | 2003-03-06 | 2004-09-23 | John H. Shadduck | Adaptive optic lens and method of making |
US7628810B2 (en) | 2003-05-28 | 2009-12-08 | Acufocus, Inc. | Mask configured to maintain nutrient transport without producing visible diffraction patterns |
US20050046794A1 (en) | 2003-06-17 | 2005-03-03 | Silvestrini Thomas A. | Method and apparatus for aligning a mask with the visual axis of an eye |
US7354980B1 (en) | 2004-03-12 | 2008-04-08 | Key Medical Technologies, Inc. | High refractive index polymers for ophthalmic applications |
DE102004017124B4 (de) * | 2004-04-07 | 2008-07-10 | Ivoclar Vivadent Ag | Härtbare Dentalmaterialien mit einer einstellbaren Transluzenz und hohen Opaleszenz |
US9872763B2 (en) | 2004-10-22 | 2018-01-23 | Powervision, Inc. | Accommodating intraocular lenses |
JP4906257B2 (ja) * | 2004-11-10 | 2012-03-28 | Hoya株式会社 | 表面処理眼内レンズの製造方法および後発白内障抑制性眼内レンズ |
US7446157B2 (en) * | 2004-12-07 | 2008-11-04 | Key Medical Technologies, Inc. | Nanohybrid polymers for ophthalmic applications |
WO2006095750A1 (ja) | 2005-03-09 | 2006-09-14 | Hoya Corporation | (メタ)アクリレート化合物およびその製造方法、(メタ)アクリレート系共重合体、(メタ)アクリレート系共重合体の製造方法ならびに軟性眼内レンズ |
US7976577B2 (en) | 2005-04-14 | 2011-07-12 | Acufocus, Inc. | Corneal optic formed of degradation resistant polymer |
EP2091584A2 (en) | 2006-12-12 | 2009-08-26 | Bausch & Lomb Incorporated | Ordered polymer system and intraocular lens |
US8158712B2 (en) | 2007-02-21 | 2012-04-17 | Powervision, Inc. | Polymeric materials suitable for ophthalmic devices and methods of manufacture |
EP2178463B1 (en) | 2007-07-23 | 2013-09-04 | PowerVision, Inc. | Accommodating intraocular lenses |
US8968396B2 (en) | 2007-07-23 | 2015-03-03 | Powervision, Inc. | Intraocular lens delivery systems and methods of use |
US9610155B2 (en) | 2008-07-23 | 2017-04-04 | Powervision, Inc. | Intraocular lens loading systems and methods of use |
CN101318029B (zh) * | 2008-06-20 | 2012-02-01 | 周辉 | 眼用可塑性高分子聚合材料及其应用 |
US10299913B2 (en) | 2009-01-09 | 2019-05-28 | Powervision, Inc. | Accommodating intraocular lenses and methods of use |
US8222360B2 (en) * | 2009-02-13 | 2012-07-17 | Visiogen, Inc. | Copolymers for intraocular lens systems |
CA2770735C (en) | 2009-08-13 | 2017-07-18 | Acufocus, Inc. | Masked intraocular implants and lenses |
USD656526S1 (en) | 2009-11-10 | 2012-03-27 | Acufocus, Inc. | Ocular mask |
EP2539351B1 (en) | 2010-02-23 | 2017-07-12 | PowerVision, Inc. | Fluid for accommodating intraocular lenses |
JP5585206B2 (ja) * | 2010-05-19 | 2014-09-10 | 東洋インキScホールディングス株式会社 | 活性エネルギー線硬化性化合物および該化合物を含有する活性エネルギー線硬化性組成物 |
WO2012006616A2 (en) | 2010-07-09 | 2012-01-12 | Powervision, Inc. | Intraocular lens delivery devices and methods of use |
CN102617784B (zh) * | 2011-02-01 | 2016-08-17 | 爱博诺德(北京)医疗科技有限公司 | 具有高折射率的丙烯酸类聚合物材料 |
CA2857306C (en) | 2011-12-02 | 2017-07-25 | Acufocus, Inc. | Ocular mask having selective spectral transmission |
WO2013107288A1 (zh) | 2012-01-19 | 2013-07-25 | 爱博诺德(北京)医疗科技有限公司 | 后房型人工晶体 |
WO2014106866A1 (en) | 2013-01-07 | 2014-07-10 | Council Of Scientific & Industrial Research | Flexible, high refractive index hydrophobic copolymer |
US9204962B2 (en) | 2013-03-13 | 2015-12-08 | Acufocus, Inc. | In situ adjustable optical mask |
US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
JP6717740B2 (ja) | 2013-03-15 | 2020-07-01 | パワーヴィジョン・インコーポレーテッド | 眼内レンズの収容および載置装置ならびにその使用方法 |
ES2914102T3 (es) | 2014-09-09 | 2022-06-07 | Staar Surgical Co | Implantes oftálmicos con profundidad de campo ampliada y agudeza visual a distancia mejorada |
US12127934B2 (en) | 2014-09-09 | 2024-10-29 | Staar Surgical Company | Method of Providing Modified Monovision to a Subject with a First Lens and a Second Lens |
CN114452440A (zh) | 2015-06-10 | 2022-05-10 | 爱尔康公司 | 人工晶状体材料和组分 |
JP7063815B2 (ja) | 2015-11-06 | 2022-05-09 | アルコン インコーポレイティド | 調節型眼内レンズおよび製造する方法 |
SG11201807531TA (en) | 2016-03-09 | 2018-09-27 | Staar Surgical Co | Ophthalmic implants with extended depth of field and enhanced distance visual acuity |
JP6784720B2 (ja) | 2018-06-01 | 2020-11-11 | 上海富吉医療器械有限公司Shanghai Chartwell Medical Instrument Co., Ltd. | ポリマー材料および眼内レンズ |
WO2020037314A1 (en) | 2018-08-17 | 2020-02-20 | Staar Surgical Company | Polymeric composition exhibiting nanogradient of refractive index |
EP3904408A4 (en) * | 2018-12-28 | 2022-08-10 | Nidek Co., Ltd. | SOFT INTRAOCULAR LENS MATERIAL AND SOFT INTRAOCULAR LENS |
JP7253139B2 (ja) * | 2019-01-31 | 2023-04-06 | 株式会社ニデック | 軟質眼内レンズ |
TR201906605A2 (ja) * | 2019-05-03 | 2020-11-23 | Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi | |
AU2020360242A1 (en) | 2019-10-04 | 2022-04-28 | Alcon Inc. | Adjustable intraocular lenses and methods of post-operatively adjusting intraocular lenses |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0263463A (ja) * | 1988-05-26 | 1990-03-02 | Alcon Lab Inc | 紫外線吸収ヒドロゲル並びにコンタクトレンズ及び眼内レンズ |
JPH02229814A (ja) * | 1988-12-19 | 1990-09-12 | Ciba Geigy Ag | フッ素含有単量体とサッカリド単量体をベースとするヒドロゲル |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4620954A (en) * | 1985-06-07 | 1986-11-04 | Ciba Vision Care Corp. | Hydrogel from ultraviolet-initiated copolymerization |
US4731079A (en) * | 1986-11-26 | 1988-03-15 | Kingston Technologies, Inc. | Intraocular lenses |
DE69122471T2 (de) * | 1990-11-07 | 1997-02-06 | Nestle Sa | Polymere und ihre Verwendung für opthalmische Linsen |
US5264465A (en) * | 1991-01-31 | 1993-11-23 | Hoya Corporation | Contact lens material and contact lens |
US5331073A (en) * | 1992-11-09 | 1994-07-19 | Allergan, Inc. | Polymeric compositions and intraocular lenses made from same |
US5507804A (en) * | 1994-11-16 | 1996-04-16 | Alcon Laboratories, Inc. | Cross-linked polyethylene oxide coatings to improve the biocompatibility of implantable medical devices |
-
1995
- 1995-02-23 JP JP7035228A patent/JP2967093B2/ja not_active Expired - Lifetime
-
1996
- 1996-02-19 CA CA002207010A patent/CA2207010C/en not_active Expired - Fee Related
- 1996-02-19 CN CN96192018A patent/CN1093769C/zh not_active Expired - Fee Related
- 1996-02-19 NZ NZ301359A patent/NZ301359A/en not_active IP Right Cessation
- 1996-02-19 AU AU46767/96A patent/AU703753B2/en not_active Ceased
- 1996-02-19 BR BR9606822A patent/BR9606822A/pt not_active IP Right Cessation
- 1996-02-19 KR KR1019970704409A patent/KR100334483B1/ko not_active IP Right Cessation
- 1996-02-19 WO PCT/JP1996/000361 patent/WO1996025962A1/ja active IP Right Grant
- 1996-02-19 ES ES96902474T patent/ES2171647T3/es not_active Expired - Lifetime
- 1996-02-19 EP EP96902474A patent/EP0811393B1/en not_active Expired - Lifetime
- 1996-02-19 DE DE69618764T patent/DE69618764T2/de not_active Expired - Lifetime
- 1996-02-19 MX MX9704748A patent/MX9704748A/es not_active IP Right Cessation
- 1996-02-21 US US08/606,046 patent/US5814680A/en not_active Expired - Lifetime
- 1996-02-23 IN IN323CA1996 patent/IN187504B/en unknown
-
1998
- 1998-06-09 HK HK98105067A patent/HK1005796A1/xx not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0263463A (ja) * | 1988-05-26 | 1990-03-02 | Alcon Lab Inc | 紫外線吸収ヒドロゲル並びにコンタクトレンズ及び眼内レンズ |
JPH02229814A (ja) * | 1988-12-19 | 1990-09-12 | Ciba Geigy Ag | フッ素含有単量体とサッカリド単量体をベースとするヒドロゲル |
Non-Patent Citations (1)
Title |
---|
See also references of EP0811393A4 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0968727A4 (en) * | 1997-12-02 | 2004-03-31 | Hoya Healthcare Corp | INTRAOCULAR LENSES AND METHOD FOR PRODUCING INFUSED INTRAOCULAR LENSES |
KR100438477B1 (ko) * | 1997-12-02 | 2004-07-03 | 호야 헬쓰케어 가부시키가이샤 | 안내 렌즈 및 일체형 안내 렌즈의 제조 방법 |
EP1961431A1 (en) * | 1997-12-02 | 2008-08-27 | Hoya Corporation | Intraocular lenses and process for producing molded-in type intraocular lenses |
US6187042B1 (en) | 1998-04-15 | 2001-02-13 | Alcon Laboratories, Inc. | Intraocular lens coating compositions |
US6210438B1 (en) * | 1998-04-15 | 2001-04-03 | Alcon Laboratories, Inc. | Bicomposite intraocular lens and method for its preparation |
US9949822B2 (en) | 1998-05-29 | 2018-04-24 | Johnson & Johnson Surgical Vision, Inc. | Intraocular lens for inhibiting cell growth and reducing glare |
US11751991B2 (en) | 2002-12-12 | 2023-09-12 | Alcon Inc. | Accommodating intraocular lenses and methods of use |
WO2007020713A1 (ja) | 2005-08-18 | 2007-02-22 | Koken Co., Ltd. | 生体内に埋設可能な細胞培養担体 |
US11484402B2 (en) | 2011-11-08 | 2022-11-01 | Alcon Inc. | Accommodating intraocular lenses |
Also Published As
Publication number | Publication date |
---|---|
CN1093769C (zh) | 2002-11-06 |
HK1005796A1 (en) | 1999-01-29 |
EP0811393B1 (en) | 2002-01-23 |
AU703753B2 (en) | 1999-04-01 |
JPH08224295A (ja) | 1996-09-03 |
EP0811393A4 (en) | 2000-06-14 |
CA2207010A1 (en) | 1996-08-29 |
CA2207010C (en) | 2009-09-08 |
US5814680A (en) | 1998-09-29 |
ES2171647T3 (es) | 2002-09-16 |
EP0811393A1 (en) | 1997-12-10 |
DE69618764T2 (de) | 2002-09-19 |
DE69618764D1 (de) | 2002-03-14 |
NZ301359A (en) | 1998-08-26 |
JP2967093B2 (ja) | 1999-10-25 |
AU4676796A (en) | 1996-09-11 |
BR9606822A (pt) | 1997-12-23 |
MX9704748A (es) | 1997-10-31 |
IN187504B (ja) | 2002-05-11 |
KR100334483B1 (ko) | 2002-06-20 |
CN1175905A (zh) | 1998-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996025962A1 (fr) | Lentille intra-oculaire souple | |
TW381014B (en) | Intraocular lens and manufacturing method for integrated intraocular lens | |
JP3641110B2 (ja) | 軟質眼内レンズ用材料 | |
ES2327224T3 (es) | Composiciones biomedicas. | |
JP5096793B2 (ja) | ポリマー組成物および眼用レンズ本体 | |
US8470034B2 (en) | Hydrophobic acrylic polymer material for an intraocular lens having enhanced flexibility due to the use of a transfer agent | |
US10626206B2 (en) | Acrylic copolymer, which is hydrophobic, cross-linked and based on cinnamic alcohol, for intraocular lenses | |
JP4144920B2 (ja) | 軟質眼内レンズ材料 | |
KR102488312B1 (ko) | 안내 렌즈 | |
JPH10339857A (ja) | 薬剤徐放性コンタクトレンズの製法およびそれによってえられた薬剤徐放性コンタクトレンズ | |
JP3222026B2 (ja) | コンタクトレンズ材料および眼内レンズ材料 | |
WO1997023523A1 (fr) | Nouveaux copolymeres constitues de trois composants et lentilles intraoculaires fabriquees a partir de ces copolymers | |
WO2001008603A1 (en) | Biomedical compositions | |
JP4431372B2 (ja) | 眼内レンズ | |
CN112204073B (zh) | 聚合物材料以及眼内透镜 | |
JP3429392B2 (ja) | 軟性眼内レンズ | |
JP3429393B2 (ja) | 軟性眼内レンズ | |
JPH04318010A (ja) | 医療用材料 | |
JP2002006268A (ja) | 紫外線吸収性軟質眼用レンズ | |
JP3558421B2 (ja) | 眼用レンズ材料およびその製法 | |
BR112019024078A2 (pt) | Materiais de lente intraocular de baixa aberração cromática e micro-injetável | |
JPH0973052A (ja) | 軟質眼内レンズ材料 | |
JPS63196606A (ja) | ヒドロゲル樹脂 | |
AU6140400A (en) | Biomedical compositions | |
JPH03173567A (ja) | 軟質眼内レンズ材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 96192018.1 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA CN KR MX NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 301359 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2207010 Country of ref document: CA Ref document number: 2207010 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996902474 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019970704409 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1996902474 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970704409 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996902474 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019970704409 Country of ref document: KR |